Significantly lower expression of BACH2 -mRNA as well as -protein in these bortezomib resistant MCL cell lines compared to bortezomib sensitive MCL cells as well as patient cells (Figure 1) suggested that BACH2 might function as a tumor suppressor in MCL cells. Here, BACH2 is linked to mantle cell lymphoma.